Moleculin Biotech, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureOct 5 →InsidersNo open-market buys or sales.→HoldersGeode 0.7%Vanguard 0.6%Vanguard Fiduciary Trust 0.4%→PeersClosest companies: AMIX, CNSP, PCSA→
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- $36.8Mlast 12 months
- Operating cash flow
- −$24.3Mlast 12 months
- Cash and equivalents
- $7.3Mat the last balance sheet
- Shares outstanding
- 7.1M shareson issue